tiprankstipranks
SIGA Technologies Inc (SIGA)
NASDAQ:SIGA
US Market
Want to see SIGA full AI Analyst Report?

SIGA Technologies (SIGA) Price & Analysis

491 Followers

SIGA Stock Chart & Stats

$6.77
-$0.07(-1.11%)
At close: 4:00 PM EST
$6.77
-$0.07(-1.11%)

Bulls Say, Bears Say

Bulls Say
Balance Sheet StrengthA cash-rich, essentially debt-free balance sheet provides durable optionality: it funds ongoing operations, supports R&D and manufacturing tech transfer, allows special dividends, and cushions the business through procurement timing volatility without needing near-term external financing.
Cash Generation QualityConsistent positive operating and free cash flow historically, with FCF tracking net income, indicates solid earnings quality and underlying cash conversion. This durability helps fund development programs and stockpile fulfillment despite episodic revenue swings.
Commercial & Geographic ExpansionNew international orders and an exclusive MENA distribution deal broaden SIGA's addressable market beyond U.S. government procurement. Expanding commercial channels and manufacturer status helps diversify revenue sources and build recurring non‑stockpile sales over the medium term.
Bears Say
Revenue And Cash-Flow VolatilityLarge year-to-year swings in revenue and cash flow reflect order-driven demand and make operating performance unpredictable. This lumpiness complicates investment planning, obscures trend assessment for margins, and increases the risk that profitable years are offset by periods of weak coverage for fixed costs.
Regulatory Uncertainty In EuropeA CHMP recommendation to withdraw an indication imposes structural headwinds to European commercialization, adding regulatory complexity and potential market access loss. Implementation steps and follow-on actions could reduce ex‑US sales opportunities and lengthen timelines to recover or replace that revenue.
Dependence On Government Contract TimingHeavy reliance on government procurements exposes SIGA to long, variable contracting cycles. Slower-than-expected contract progress creates persistent timing risk for large orders, sustaining revenue lumpiness and limiting predictable multi-quarter visibility for cash generation and operational scaling.

SIGA Technologies News

SIGA FAQ

What was SIGA Technologies Inc’s price range in the past 12 months?
SIGA Technologies Inc lowest stock price was $4.29 and its highest was $9.62 in the past 12 months.
    What is SIGA Technologies Inc’s market cap?
    SIGA Technologies Inc’s market cap is $338.88M.
      When is SIGA Technologies Inc’s upcoming earnings report date?
      SIGA Technologies Inc’s upcoming earnings report date is Aug 11, 2026 which is in 95 days.
        How were SIGA Technologies Inc’s earnings last quarter?
        SIGA Technologies Inc released its earnings results on May 07, 2026. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.05.
          Is SIGA Technologies Inc overvalued?
          According to Wall Street analysts SIGA Technologies Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does SIGA Technologies Inc pay dividends?
            SIGA Technologies Inc pays a Notavailable dividend of $0.6 which represents an annual dividend yield of N/A. See more information on SIGA Technologies Inc dividends here
              What is SIGA Technologies Inc’s EPS estimate?
              SIGA Technologies Inc’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does SIGA Technologies Inc have?
              SIGA Technologies Inc has 71,644,400 shares outstanding.
                What happened to SIGA Technologies Inc’s price movement after its last earnings report?
                SIGA Technologies Inc reported an EPS of -$0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
                  Which hedge fund is a major shareholder of SIGA Technologies Inc?
                  Currently, no hedge funds are holding shares in SIGA
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    SIGA Technologies Stock Smart Score

                    Company Description

                    SIGA Technologies Inc

                    SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

                    SIGA Technologies (SIGA) Earnings & Revenues

                    SIGA Earnings Call

                    Q1 2026
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The call presents a generally positive strategic and financial position driven by a strong cash balance, shareholder-friendly capital return, confirmed near-term international orders, regional commercial expansion via an exclusive Hikma agreement, and concrete pipeline progress (pediatric IND and PEP pathway). Offsetting these positives are the quarter's minimal deliveries and lumpy revenue profile, a small quarterly loss, a CHMP recommendation to withdraw the MPOXX indication in Europe, and slower progress toward a new U.S. government contract. Overall, the positives (liquidity, contracts, partnerships, and pipeline momentum) outweigh the near-term operational and regulatory headwinds.View all SIGA earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Emergent Biosolutions
                    Esperion
                    Organogenesis Holdings
                    Aquestive Therapeutics

                    Ownership Overview

                    1.58%12.70%0.58%74.39%
                    0.58% Other Institutional Investors
                    74.39% Public Companies and
                    Individual Investors
                    Popular Stocks